Hippocratic AI Secures Major Investment to Innovate Healthcare
PALO ALTO, Calif. – Hippocratic AI, a groundbreaking company focused on creating safety-driven Large Language Models (LLMs) for healthcare, has announced a significant investment from NVentures, NVIDIA's venture capital division. This funding is part of an extended Series A round, which has successfully raised a total of $137 million. NVentures, along with Greycroft and Leo Shapiro of 7Wire Ventures, has contributed an additional $17 million, boosting the total funds to meet the increasing demand for healthcare innovation.
Investment Details and Collaborations
The Series A funding round was co-led by Premji Invest and General Catalyst, drawing participation from notable investors including SV Angel and Memorial Hermann Health System. Additional support came from existing investors like Andreessen Horowitz, Cincinnati Children’s Hospital, WellSpan Health, and Universal Health Services (UHS). This substantial funding demonstrates strong confidence in Hippocratic AI's mission to transform how healthcare is delivered and experienced.
Technological Innovations and Collaboration with NVIDIA
Hippocratic AI's partnership with NVIDIA aims to harness cutting-edge technology to boost its production abilities. By utilizing NVIDIA’s NIM microservices, the collaboration intends to offer low-latency, long-context conversational capabilities that are vital for patient-clinician interactions. These innovative features were highlighted at the NVIDIA GTC global AI conference, showcasing advancements like prefix caching, speculative decoding, and prefill/decode disaggregation, designed specifically for real-time conversational AI.
Revolutionizing Patient Care
During the announcement, Munjal Shah, the co-founder and CEO, expressed his excitement about the collaboration, emphasizing that working alongside NVIDIA has enabled significant advancements in healthcare AI technology. These breakthroughs are set to create LLMs that can engage more empathetically and effectively with patients, ultimately improving the overall healthcare experience.
Enhancing Patient Trust
Kimberly Powell, NVIDIA's vice president of healthcare, highlighted how generative AI can transform the healthcare industry. She pointed out that this technology not only enhances the capabilities of healthcare services but also helps build trust between patients and clinicians. The safety-first approach that Hippocratic AI advocates relies on NVIDIA’s advanced technologies, fostering personalized and natural interactions that align with the increased expectations of patient care.
About Hippocratic AI
Hippocratic AI is on a mission to create the first safety-focused LLM dedicated to healthcare. The company believes that by developing a secure LLM, it can significantly enhance access to healthcare and improve health outcomes on a global scale. Co-founded by individuals with extensive experience in both medicine and AI, Hippocratic AI has secured a total of $137 million in funding from a variety of respected investors. This financial backing highlights the promise and commitment of Hippocratic AI in revolutionizing the future of healthcare technology.
Frequently Asked Questions
What is the primary mission of Hippocratic AI?
The mission of Hippocratic AI is to develop the first safety-focused Large Language Model for healthcare to enhance accessibility and improve health outcomes.
How much funding has Hippocratic AI recently secured?
Hippocratic AI has secured a total of $137 million in funding, including a recent investment from NVentures.
Who are some of Hippocratic AI's key investors?
Key investors include NVentures, General Catalyst, Andreessen Horowitz, and Greycroft, among others.
What technologies does Hippocratic AI use in its platform?
Hippocratic AI leverages NVIDIA’s microservices to enable low-latency conversational capabilities in healthcare settings.
How does this investment impact patient care?
The investment allows Hippocratic AI to enhance its technological capabilities, leading to improved, more personalized healthcare interactions.